Astrid E. Greijer
Amsterdam, NH 1081HV, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age.
Journal: Human vaccines & immunotherapeutics
Published: March 28, 2022
Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma.
Journal: Cancers
Published: February 07, 2018
Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.
Journal: Journal of medical virology
Published: October 19, 2016
Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells.
Journal: Journal of virological methods
Published: July 13, 2016
Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Journal: International journal of cancer
Published: December 28, 2015
Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: January 09, 2015
Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: December 16, 2014
BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.
Journal: Reviews in medical virology
Published: May 28, 2013
Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2013
Epstein-Barr virus-encoded BARF1 protein is a decoy receptor for macrophage colony stimulating factor and interferes with macrophage differentiation and activation.
Journal: Viral immunology
Published: October 16, 2012
Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.
Journal: Journal of virology
Published: August 17, 2012
Last Updated: 09/26/2026